Harris Williams advises Medical Knowledge Group, LLC on its sale to Novo Holdings A/S

RICHMOND, Virginia–(BUSINESS WIRE)–Harris Williams, an international investment bank specializing in mergers and acquisitions advisory services, announces that it has advised Medical Knowledge Group, LLC (MKG), a portfolio company of Court Square Capital Partners (Court Square ) and Aisling Capital (Aisling), in connection with its sale to Novo Holdings A/S (Novo Holdings). MKG is an analytics-driven go-to-market platform that delivers targeted insights and solutions to healthcare providers that maximize the clinical and market potential of biopharmaceutical client brands. The transaction was led by Paul Hepper, Brian Jones and Hampton Cokeley of Harris Williams Healthcare & Life Sciences (HCLS) Group and Dan Linsalata of the company’s Technology Group.

“The MKG team has done a tremendous job building a leading, analytics-driven go-to-market services platform with truly differentiated capabilities and solutions in one of the most attractive sectors of outsourced pharmaceutical services” , said Paul Hepper, managing director at Harris Williams. “It was a pleasure to work with the MKG and Court Square teams on this transaction and we believe the company has found a fantastic new partner in Novo Holdings.”

“The market for outsourced pharma commercialization services continues to see strong growth as biopharmaceutical companies increasingly recognize the value proposition of companies that can use differentiated analytics tools to drive outsized results in their commercialization solutions. said Dan Linsalata, managing director at Harris Williams. “Differentiated platforms like MKG will continue to benefit disproportionately from market tailwinds in the industry and we look forward to seeing the continued success and growth of the business in partnership with Novo Holdings.”

MKG is a New York-based, analytics- and technology-focused, independent multi-channel marketing solutions provider serving the marketing, medical affairs and stakeholder relations teams of biopharmaceutical companies throughout the cycle. life of the product. MKG has a diverse list of clients ranging from niche biotech and diagnostics companies to some of the industry’s largest global companies. The company is an analytics-centric strategic marketing solutions provider that partners with clients to translate the complex science and data behind their brands into market-shaping strategies that maximize their clinical and market potential.

Court Square is a middle-market private equity firm with one of the most experienced investment teams in the industry. Since 1979, Court Square has made more than 240 platform investments, helping executives, families and founding owners build their businesses into leaders in their respective markets. Court Square invests in companies that have compelling growth potential in the business services, industrials, healthcare, technology and telecommunications sectors. Court Square has $7.5 billion in assets under management and is based in New York.

Aisling is a leading life sciences investment firm that invests in products, technologies and global companies that advance human health. Since 2000, Aisling has raised over $2 billion through five funds. Aisling’s team’s combination of clinical, operational and financial experience enables the company to partner with entrepreneurs to identify, execute and realize investments using a variety of life science industry structures. the life.

Novo Holdings is a private limited company wholly owned by the Novo Nordisk Foundation. It is the holding company of the Novo Group, consisting of Novo Nordisk A/S and Novozymes A/S, and is responsible for managing the assets of the Novo Nordisk Foundation. Novo Holdings is recognized as a leading international life sciences investor focused on creating long-term value. As a life sciences investor, Novo Holdings provides seed and venture capital to early-stage companies and takes significant equity positions in growing and established companies. Novo Holdings also manages a large portfolio of diversified financial assets.

Harris Williams, an investment bank specializing in M&A advisory services, defends sellers and buyers of businesses around the world through critical stages and provides expert advice throughout the life of their businesses . By collaborating as one company across industry groups and geographies, the company helps its clients achieve results that support their goals and strategically create value. Harris Williams is committed to excellence in execution and to building lasting and valuable relationships based on mutual trust. Harris Williams is a subsidiary of PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams HCLS Group has experience across a wide range of industries, including healthcare providers; payers and payer services; outsourced pharmaceutical services; medical device supply chain; health informatics; and pharmacy. For more information on the HCLS Group and other recent transactions, visit the HCLS Group section of the Harris Williams website.

The Harris Williams Technology Group advises large private and public companies, founders and private equity, private equity and venture capital firms on mergers and acquisitions and capital raising transactions worldwide. The technology group has deep domain expertise in software and technology services and dedicated focus areas in a variety of vertical software applications and end markets. For more information about the Technology Group and its recent transactions, visit the Technology Group section of the Harris Williams website.

Harris Williams LLC is a registered broker and member of FINRA and SIPC. Harris Williams & Co. Ltd is a limited company incorporated under the laws of England with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, United Kingdom, registered with the Registrar of Companies for England and Wales (registration number registration 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court in Frankfurt am Main, Germany under number HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main. -le-Main, Germany (e-mail address: hwgermany@harriswilliams.com). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT number DE321666994). Harris Williams is a trading name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH operate.

Donald E. Patel